Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.500
+0.070 (2.88%)
At close: Nov 20, 2024, 4:00 PM
2.350
-0.150 (-6.00%)
Pre-market: Nov 21, 2024, 4:13 AM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.72 million as of November 21, 2024. Its market cap has decreased by -18.40% in one year.
Market Cap
3.72M
Enterprise Value
-1.06M
1-Year Change
-18.40%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.72M, a decrease of -90.98%. That is a compound annual growth rate of -56.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.72M | 189.01% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Pharma Holdings | 3.62M |
| Azitra | 3.50M |
| Lixte Biotechnology Holdings | 3.50M |
| Alaunos Therapeutics | 3.49M |
| NovaBay Pharmaceuticals | 3.42M |
| Synaptogenix | 3.42M |
| Titan Pharmaceuticals | 3.35M |
| Virpax Pharmaceuticals | 3.28M |